Welcome to the Reuters.com BETA. Read our Editor's note on how we're helping professionals make smart decisions.
Skip to main content

Healthcare & Pharmaceuticals

El Salvador inks deal with Pfizer for 4.4 mln COVID-19 vaccine doses

1 minute read

A healthcare worker shows a vial of Pfizer/BioNTech coronavirus disease (COVID-19) vaccine in Rio de Janeiro, Brazil May 4, 2021. REUTERS/Ricardo Moraes

SAN SALVADOR, May 4 (Reuters) - El Salvador's president Nayib Bukele said on Twitter on Tuesday night that the Central American nation has signed an agreement with Pfizer Inc (PFE.N) for 4.4 million COVID-19 vaccine doses.

"With this purchase, we guarantee uninterrupted immunization for our entire target population," said Bukele.

Reporting by Nelson Renteria; Writing by Anthony Esposito; Editing by Tom Hogue

Our Standards: The Thomson Reuters Trust Principles.

More from Reuters